Advanced Malignant Solid Tumor Clinical Trial
Official title:
A Phase I/IIa Clinical Trial to Evaluate the Safety,Tolerability,Pharmacokinetics and Preliminary Effectiveness of IAE0972 in Patients With Advanced Malignant Solid Tumors.
This is a Phase I/IIa Clinical Trial to Evaluate the Safety,Tolerability,Pharmacokinetics and Preliminary Effectiveness of IAE0972 in Patients With Advanced Malignant Solid Tumors.
The study includes three phases: dose escalation (Phase Ia), dose extension (Phase Ib), and clinical exploration (Phase IIa).First, the Phase Ia dose escalation will be carried out. After finishing the Phase 1a dose escalation, the Phase Ib dose extension study can be carried out in the MTD dose which is obtained from Phase 1a . After Phase Ia &1b are completed and RP2D is obtained, Phase IIa clinical exploratory research can be carried out. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04864379 -
Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT04165590 -
Plasmodium Immunotherapy for Advanced Malignant Solid Tumors
|
Phase 1/Phase 2 | |
| Terminated |
NCT05098405 -
First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06150183 -
Safety and Preliminary Efficacy of BNT314 With or Without an Immune Checkpoint Inhibitor in Cancer Patients With Malignant Solid Tumors
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05911984 -
A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Preliminary Efficacy of 9MW3811 in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT03171220 -
Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04241835 -
A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function
|
Phase 1 | |
| Active, not recruiting |
NCT03662815 -
Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor
|
Phase 1 | |
| Not yet recruiting |
NCT06166472 -
A Study to Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of AK132 in Advanced Malignant Solid Tumor
|
Phase 1 | |
| Recruiting |
NCT05477849 -
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients With Solid Tumors
|
Phase 1 | |
| Not yet recruiting |
NCT04275050 -
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets
|
Phase 1 | |
| Recruiting |
NCT04758897 -
Clinical Study of VG161 in Subjects With Advanced Malignant Solid Tumors
|
Phase 1 |